Amdocs, Ltd.

DOX
Marn v. Amdocs Limited et al.

On March 31, 2021, pre-market, Jehoshaphat Research published a short-seller report addressing Amdocs, which alleged, inter alia, that Amdocs overstated its profits, evidenced by steady parent profits despite declining subsidiary profits; that there was a concerning pattern of reputable auditors resigning, only to be replaced by "scandal-plagued or tiny shops"; that Amdocs "window-dressed" its balance sheets to keep its large borrowing a secret, namely by paying down its debt just prior to the end of each quarter, therefore showing a debt-free balance sheet on that day, before re-borrowing the money shortly thereafter; and that all of the foregoing was corroborated by former employees and direct competitors of the Company, who noted that Amdocs was losing AT&T as a customer, as well as a former American Amdocs executive, who stated that the Company's "US business was declining at a rate of [around] 7% annually . . . but then we would see the company [publish results that] say North America is stable." On this news, Amdocs' ordinary share price fell $9.19 per share, or 11.58%, to close at $70.15 per share on March 31, 2021.

Lead Plaintiff deadline
June 8, 2021
class period
December 13, 2016
to
March 30, 2021
Case Documents
No documents available. Contact us if you need a case document.